Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01747785 · ClinicalTrials.gov registry record

Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction

A clinical trial, sponsored by Mayo Clinic.

Terminated
Registry status
21
Enrollment target

NCT01747785: Clinical Trial study, sponsored by Mayo Clinic.

NCT01747785 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01747785 was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
21 participants
Enrollment target

Study Summary

This study is being done to study how well the heart contracts and relaxes during exercise. In addition to traditional measures of heart function, we will use a new computer program that may improve understanding of why people feel shortness of breath or fatigue.

Primary Outcome

Myocardial deformation imaging (e.g. strain, strain rate, torsion) requires clear 2-dimensional echocardiography images that will be obtain at rest and during mild and moderate intensity exercise. Images will be captured during 6-10 minute bouts of exercise on a tilting exercise table. Comparisons will be made on resting and exercise values between groups. Our hypothesis is that strain rate will not increase in patients at risk of heart failure demonstrating lack of cardiovascular reserve.

Interventions

  • OTHER Cardiopulmonary exercise test
  • OTHER Cardiac rehabilitation
  • OTHER Myocardial deformation imaging

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2012-06
Est. Completion 2015-07
Mayo Clinic

2,844 total trials

Why NCT01747785 stopped before completion

NCT01747785 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.

The record links to 0 conditions, and to 3 interventions - of which Cardiopulmonary exercise test is the first listed.

NCT01747785 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01747785 about?

NCT01747785 is a clinical study titled "Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction". This study is being done to study how well the heart contracts and relaxes during exercise. In addition to traditional measures of heart function, we will use a new computer program that may improve understanding of why people feel shortness of breath or fatigue.

What is the current status of trial NCT01747785?

This trial is currently terminated. The enrollment target is 21 participants. The study started on 2012-06. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01747785?

The interventions under investigation include: Cardiopulmonary exercise test (OTHER), Cardiac rehabilitation (OTHER), Myocardial deformation imaging (OTHER).

Who is sponsoring clinical trial NCT01747785?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01747785, the US trial registry maintained by the National Library of Medicine. NCT01747785 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.